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Background: Latrophilins (LPHNs) are a small family of neuronal adhesion-GPCRs originally discovered as receptors for
the black widow spider toxin α-latrotoxin. Mutations in LPHN3 have recently been identified as risk factors for attention
deficit hyperactivity disorder (ADHD) in humans, but their physiological function has remained elusive. In this study, we
tested two hypotheses regarding LPHN3 function: (1) LPHN3 regulates synaptic transmission by modulating probability
of release; and (2) LPHN3 controls synapse development and the abundance of synapses.
Results: We manipulated LPHN3 expression in mouse layer 2/3 (L2/3) pyramidal neurons and examined the
consequences on the L2/3 to L5 cortical microcircuit. Employing an optogenetic strategy combined with shRNA
knockdown of LPHN3, we found that LPHN3 did not influence probability of release at synapses formed by L2/3
neurons onto L5 pyramidal cells. The strength of L2/3 afferent input to L5, however, was weakened by loss of LPHN3.
Using Synaptophysin-GFP as an anatomical marker of presynaptic terminals, we found that the density of synapses
formed by L2/3 axons in L5 was reduced when LPHN3 was lost. Finally, we investigated the structural organization
of the extracellular domain of LPHN3. We used single particle negative stain electron microscopy to image the
extracellular domain of LPHN3 and showed that the Olfactomedin and Lectin domains form a globular domain on
an elongated stalk. Cell-based binding experiments with mutant proteins revealed that the Olfactomedin domain
was required for binding to FLRT3, whereas both the Olfactomedin and Lectin domains were involved in binding
to Teneurin 1. Mutant LPHN3 lacking the Olfactomedin domain was not capable of rescuing the deficit in
presynaptic density following knockdown of endogenous LPHN3.
Conclusions: We find that LPHN3 regulates the number of synapses formed by L2/3 neurons in L5 and the
strength of synaptic drive from the L2/3-L5 pathway. The Olfactomedin domain of LPHN3 is required for this effect
on synapse number and binding to its postsynaptic ligand FLRT3. We propose that LPHN3 functions in synaptic
development and is important in determining the connectivity rates between principal neurons in the cortex.Background
Latrophilins (LPHNs) are G protein-coupled receptors
(GPCRs) with adhesion-like extracellular domains [1]. Re-
cently, LPHN3 has been linked to attention deficit hyper-
activity disorder (ADHD); polymorphisms in LPHN3 are
risk factors for ADHD [2,3] and LPHN3 haplotype can pre-
dict the efficacy of stimulant treatment [4] and human cor-
tical electrophysiology [5]. This mounting genetic evidence* Correspondence: anirvan.ghosh@roche.com
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cortical function.
Latrophilins were discovered due to their role as re-
ceptors for α-latrotoxin, a venom protein produced by
spiders of the Latrodectus genus [1]. α-latrotoxin is a po-
tent exocytotic agent whose effect on presynaptic termi-
nals can be mediated by LPHN1, suggesting that LPHNs
are functionally coupled to the presynaptic active zone [1].
Known presynaptic GPCRs are predominantly metabotro-
pic neurotransmitter receptors that modulate synaptic
transmission by influencing the function of the active zone
and voltage-gated calcium channels [6]. The combination
of α-latrotoxin toxicology and the precedent set byral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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speculation that LPHNs might also modulate synaptic
transmission [7].
Unlike metabotropic receptors, however, the endogen-
ous ligands for the LPHNs are transmembrane proteins
(the FLRTs and Teneurins) rather than small diffusible
molecules [7-9]. Consequently, the concentration of avail-
able ligand for LPHNs is likely to vary only slowly over
time, potentially making LPHN signaling inappropriate for
fast modulation of synaptic transmission. The function of
LPHNs might then manifest at longer, developmental
timescales. Indeed, we previously found that postsynaptic
fibronectin leucine-rich transmembrane (FLRT) proteins
regulate glutamatergic synapse density in hippocampal
neurons in vitro and in vivo [8]. Their participation in
trans-synaptic interactions may imply a role for LPHNs in
regulating synaptic development.
While LPHN1 and LPHN3 are broadly expressed in the
brain, there is evidence that FLRTs and Teneurins (TENs)
show differential patterns of expression [8,10-13]. In the
neocortex, Flrt1 and Flrt3 expression is highest in layer 2/3
(L2/3) and L5, while Flrt2 seems to be more broadly
expressed across layers [8,12,13]. Of the Teneurin genes,
Tenm1 shows the strongest expression, predominately in
L5 and L6 [10-13]. The broad expression of LPHNs and
more restricted expression of its FLRT and TEN ligands
may further imply that LPHNs may interact with different
ligands in different contexts.
Since α-latrotoxin induces synaptic vesicle release and
LPHN3 mutations are linked to cortical function through
their association with ADHD, we chose to investigate two
hypotheses regarding the role of presynaptic LPHN3 at
cortical synapses: (1) LPHN3 modulates presynaptic
vesicle release; and (2) LPHN3 regulates synapse develop-
ment. We manipulated layer 2/3 (L2/3) pyramidal neurons
in the mouse cortex in vivo by in utero electroporation,
and examined the L2/3 to L5 microcircuit. We found that
loss of LPHN3 reduced the strength of L2/3 input to L5
and the number of synapses formed by L2/3 axons, but
that manipulating LPHN3 levels did not affect the prob-
ability of release at L2/3 terminals. We then investigated
the structure of the LPHN3 extracellular domain and
mapped the regions involved in interaction with its li-
gands, the FLRTs and Teneurins (TENs). Binding to both
FLRTs and TENs depends on regions found within the
distal globular domain, but we found that the Olfactome-
din domain is required for interaction with FLRTs while
both the Lectin and Olfactomedin domains are involved
in the interaction with TENs. Using LPHN3 deletion mu-
tants in a functional rescue experiment, we find that the
Olfactomedin but not Lectin domain is required to sup-
port synapse development. Our data indicate that the
architecture of the extracellular domain of LPHN3 con-
tains a distal ‘ligand binding module’ with differentiableFLRT3 and TEN1 binding sites, situated on an elongated
and potentially flexible stalk long enough to span the syn-
aptic cleft. We propose that LPHN3 does not regulate pre-
synaptic function, but rather interacts trans-synaptically
with FLRTs during synapse development and contributes
to determining the density of synaptic terminals formed
by axons of cortical pyramidal neurons.
Results
LPHN3 regulates the strength of L2/3 input to L5
Since LPHN3 is broadly expressed in the cortex and FLRTs
and TENs are expressed in L5, we decided to investigate
the role of LPHN3 at synapses of the L2/3 to L5 pathway, an
important canonical element of cortical circuitry [8,10-13].
To test whether LPHN3 affects synapses formed by the
axons of L2/3 pyramidal neurons, we used in utero electro-
poration to express Channelrhodopsin 2 (ChR2) in L2/3 pyr-
amidal neurons with or without an shRNA to knock down
LPHN3 expression (shLPHN3). This shRNA has been pre-
viously described, and strongly and specifically knocks
down LPHN3 [8]. This strategy afforded us several advan-
tages compared to more conventional techniques: (1)
while a stimulating electrode in the cortex would stimulate
a mixed population of axons, optogenetic stimulation al-
lows for the stimulation of a pure population of L2/3
axons; and (2) co-electroporation of Cre-dependent ChR2
guarantees that only axons in which LPHN3 has been
knocked down are light-sensitive, giving selective stimula-
tion of a sparse manipulated population of axons on a
wildtype background.
At 2 weeks of age, acute slices of somatosensory cortex
were cut from electroporated mice. ChR2-expressing cell
bodies in L2/3 and axons in L5 were clearly visible by YFP
epifluorescence (Figure 1A,B). Recordings were made from
L5 pyramidal neurons in regions where YFP-positive axons
were abundant (Figure 1C). Slices were surveyed to ensure
L5 neurons were not also expressing ChR2. Blue light
flashes over L5 frequently evoked polysynaptic excitation
under our conditions, so we decided to block AMPARs and
record NMDAR-mediated EPSCs to isolate pure mono-
synaptic L2/3 inputs to L5.
In order to determine whether the strength of the afferent
pathway was affected by LPHN3, we had to control for
variability in the density of electroporated neurons between
mice since the number of ChR2-expressing neurons dir-
ectly contributes to the number of light-sensitive synapses
and therefore the strength of light-evoked L2/3 inputs to
L5. When field potentials were recorded with an electrode
positioned adjacent to the whole cell pipette (Figure 1C,D),
we observed a small, fast signal time-locked to the light
stimulus (Figure 1E). In the presence of tetrodotoxin (TTX)
to block action potentials, the amplitude of this axonal field
potential (AfP) was reduced by approximately 50%, while
the EPSC was completely suppressed (Figure 1E). This
Figure 1 LPHN3 regulates the strength of synaptic input from L2/3 to L5. (A-C) Images of an acute coronal slice from a P14 mouse
electroporated at E16 to express ChR2-YFP in L2/3 PNs. (B, C) A L5 PN is filled with Alexa 595 during a whole cell recording with a pipette nearby
to record the axonal field potential (AfP). (D) Schematic of the optogenetic electrophysiology experiment. A whole cell recording from a L5 PN is
used to record EPSCs while the AfP is recorded nearby. Flashes of blue light over the recorded cell (blue circle) are used to stimulated
ChR2-expressing axon of L2/3 neurons in L5. (E) Example average EPSC (top: Vhold = +40 mV) and AfP (bottom) before (black) and after (red) 1 μM
TTX. (F) Example recordings with small (green), medium (blue), and large (red) AfPs from different Control, shLPHN3, and Rescue slices. (G)
shLPHN3 reduced mean EPSC amplitude versus Control and Rescue (one-way ANOVA, F(2,68) = 3.34, P = 0.04: Control 81.72 ± 11.42 pA, n = 25;
shLPHN3 49.5 ± 5.8 pA, n = 23; Rescue 83.48 ± 12.42 pA, n = 23). (H) AfP amplitude did not differ (one-way ANOVA, F(2,68) = 1.06, P = 0.35: Control,
4.44 ± 0.27 pA, n = 25; shLPHN3, 3.89 ± 0.39 pA, n = 23; Rescue, 4.68 ± 0.48 pA, n = 23). (I) Plot of AfP vs. EPSC amplitude for Control (black), shLPHN3
(red), and Rescue (gray) inputs, fitted with a line through the origin. The slopes of the fitted lines differed between conditions (extra sum-of-squares F
test, F(2,68) = 4.82, P = 0.01). The slope of the shLPHN3 condition (11.14 pA/μV, 95% confidence interval 7.82-14.46) was determined to be significantly
different from Control (18.91, 14.69-23.12) and Rescue (17.97, 14.53-21.42) since the 95% confidence intervals were non-overlapping.
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that a large fraction of the AfP is generated by axonal action
potentials. We posit that current fluxed by ChR2 itself gen-
erates the TTX-insensitive portion of the AfP. Since both
the fiber volley and ChR2 current are related to the local
number of ChR2-expressing axons, and the AfP amplitude
seemed to increase with subjective YFP fluorescence inten-
sity, we decided to use the AfP as a measurement of the
number of axons stimulated.We found that light stimulation evoked AfPs and EPSCs
of a wide range of amplitudes, but that EPSC amplitude
scaled with AfP amplitude (Figure 1F). When we compared
the amplitudes of EPSCs across conditions, we found that
the amplitude of LPHN3 deficient inputs was reduced by
39% relative to control inputs, and that this effect was fully
rescued by co-electroporation of shRNA-resistant LPHN3
(Figure 1G). For these same inputs, the mean AfP did not
differ by condition (Figure 1H), indicating that the number
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ally different between conditions. The AfP and EPSC ampli-
tudes were correlated and the slope of this relationship was
41% smaller in the shLPHN3 condition relative to Control
and Rescue (Figure 1I). This reduced input-output relation-
ship indicates that the L2/3-L5 microcircuit is weakened
when L2/3 neurons lack LPHN3. Loss of LPHN3 could
lead to two different kinds of defects that would weaken
L2/3 input to L5: (1) reduced synaptic probability of release;
or (2) lower axonal synapse density.
LPHN3 does not affect probability of release at
L2/3-L5 synapses
In order to see whether LPHN3 affects presynaptic func-
tion, we began by measuring the paired pulse ratio
(PPR) of light-evoked L2/3 inputs to L5. Since the slow
decay of the NMDAR-mediated EPSC leads to summa-
tion of synaptic currents within the timescale of short-
term plasticity, we averaged responses to a single stimulus
or 20 Hz stimulus pairs and subtracted the former from
the latter to get a pure ‘second’ EPSC (Figure 2A). The
PPR was then calculated from the subtracted trace and the
average single EPSC. Using this paradigm, we found that
shLPHN3 did not affect the PPR at L2/3 inputs to L5 pyr-
amidal neurons (Figure 2B).
To more directly examine whether LPHN3 affects prob-
ability of release, we recorded NMDAR EPSCs in the pres-
ence of MK801, an NMDAR antagonist that irreversibly
blocks open NMDAR channels [14,15]. When a stimulus is
delivered, only NMDARs at active synapses are blocked
and the bulk EPSC becomes progressively smaller with each
stimulus. In this way, synapses with a high probability of re-
lease will be suppressed more quickly than those with a low
probability of release. The rate of MK801 block at LPHN3-
deficient inputs did not differ from control inputs, indicat-
ing that the probability of release was not affected by theFigure 2 LPHN3 does not modulate probability of release at L2/3-L5
at +40 mV for Control and shLPHN3 electroporation conditions. Black trac
are responses to two flashes at 20 Hz, and red traces are the subtraction. T
red and black traces. (B) The PPRs of L2/3 inputs did not differ between c
shLPHN3, 0.62 ± 0.04 n = 34). (C) Example average NMDAR EPSCs of conse
(D) Plot of normalized NMDAR EPSC amplitude by stimulus number for C
amplitude to reach 50% of baseline did not differ between Control (98.5 ±
P = 0.39). All descriptive statistics and graphs are mean ± SEM.loss of LPHN3 (Figure 2C,D). Together these experiments
suggest that LPHN3 is not involved in modulating pre-
synaptic function at synapses formed by L2/3 axons in L5.
LPHN3 controls the number of synapses formed by
L2/3 axons
To determine whether LPHN3 affects the number of
synapses formed by L2/3 axons, we electroporated L2/3
neurons with plasmids to express a set of fluorescent re-
porters; tdTomato to fill the cells, and Histone 2b-GFP
and Synaptophysin-GFP (Syp-GFP) to mark nuclei and
presynaptic terminals, respectively [16]. GFP-positive
nuclei were apparent in L2/3, tdTomato-filled axons and
dendrites were abundant in L2/3, unbranched axons tra-
versed through L4 radially, and axons ramified extensively
in L5 (Figure 3A). At high magnification, Syp-GFP puncta
could be seen decorating tdTomato axons, often localizing
to axonal varicosities (Figure 3B,C). When we counted
Syp-GFP puncta along tdTomato axons, we found that
shLPHN3 reduced the density of synaptic puncta by 34%
at P14 (Figure 3D) and 49% at P21 (Figure 3E), and co-
electroporation with shRNA-resistant LPHN3 restored
synaptic puncta density to control levels. Combined with
our electrophysiology results (Figure 2), this experiment
indicates that LPHN3 regulates the strength of L2/3 input
to L5 and controls the number of synapses made by L2/3
axons in L5.
The extracellular domain of LPHN3 consists of two
globular domains separated by a semi-rigid glycosylated
linker region
To determine the overall architecture of the extracellular
domain of purified LPHN3, we used single particle nega-
tive stain electron microscopy. To ensure sample homo-
geneity for the EM data collection, the purified protein
was fractionated by size exclusion chromatography (SEC)synapses. (A) Example average light-evoked NMDAR EPSCs recorded
es are responses to a single light flash (blue arrowhead), blue traces
he PPR was then calculated as the ratio of the peak amplitudes of
onditions (t-test, t(68) = 1.896, P = 0.06. Control, 0.54 ± 0.03, n = 36;
cutive sets of 25 sweeps recorded in the presence 40 μM MK 801.
ontrol and shLPHN3 inputs. The mean number stimuli for the
8.4, n = 10) and shLPHN3 (89.6 ± 5.9, n = 11) conditions (t(19) = 0.88,
Figure 3 LPHN3 controls the density of synapses formed by L2/3 axons in L5. (A) Confocal image of GFP and tdTomato in a slice of
somatosensory cortex from a P21 mouse electroporated in utero to express H2b-GFP, myrTdTomato, and Synaptophysin-GFP. Scale bar = 100 μm.
(B, C) Example confocal images of tdTomato-positive axons in L5 decorated with Syp-GFP puncta (white arrowheads). Scale bar = 5 μm. (D, E)
shLPHN3 axons, but not Rescue axons, have fewer Syp-GFP puncta than controls at both P14 (One-way ANOVA, F(2,104) = 4.49, P = 0.01: Control,
2.1 ± 0.2 puncta per 10 μm, n = 37; shLPHN3, 1.4 ± 0.2, n = 32; Rescue, 2.2 ± 0.2, n = 38) and P21 (One-way ANOVA, F(2,117) = 10.13, P <0.0001:
Control, 2.0 ± 0.1, n = 40; shLPHN3, 1.0 ± 0.1, n = 37; Rescue, 1.8 ± 0.2, n = 43).
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on the EM grid (Figure 4A,B). From the raw images it is
apparent that the ectodomain of LPHN3 is composed of
two globular domains separated by a variable distance
(Figure 4C,D). To improve the signal-to-noise ratio, raw
images were subjected to several rounds of averaging. The
class averages of the single particles invariably show two
globular domains (Figure 4D). Interestingly, the two globu-
lar domains are separated by a semi-rigid domain of vari-
able length, too thin to visualize by EM (Figure 4D). This
domain is composed by a stretch of approximately 70
amino acids enriched with Ser/Thr consistent with an O-
linked glycosylation domain. The distance between the two
domains varies between approximately 33 and 153 Å but
the majority of the particles had a separation of approxi-
mately 105 Å (Figure 4E). Although these different dis-
tances simply reflect the variability of how each particlewas deposited and stained on the grid, they indicate that
the globular domains are separated in solution. Moreover,
because when fully extended the distance between two
amino acids is approximately 3.6 Å, and 65 residues can
bridge approximately 230 Å, our data indicate that some
stable secondary structure is probably present in the linker.
By measuring the size of the two globular domains we find
that they are not identical (71 Å and 80 Å) (Figure 4F). Al-
though at this resolution we cannot identify them with cer-
tainty, based on the length of their amino acid sequence,
we speculate that the larger globular domain likely repre-
sents the Lectin/Olfactomedin domains (approximately 470
amino acids) whereas the smaller domain (approximately
385 amino acids) likely consists of the Hormone Receptor
Domain (HRD), GPCR Autoproteolysis Inducing (GAIN)
domain, and GPCR Proteolysis Site (GPS) (Figure 4H). This
result is consistent with the size of the available crystal
 Olf LecHRDGAIN
Figure 4 The extracellular domain of LPHN3 consists of two globular domains separated by an O-glycosylated stalk. (A) Coomassie blue
stained gel of purified ecto-LPHN3 protein that was subjected to SEC in (B). (B) SEC of the purified extracellular domain of LPHN3. The dashed line at
volume 0 indicates the beginning of the injection. Fractions were collected between red lines. Fraction C3 was used for EM analysis. Ev and Iv indicate
the excluded and included volumes, respectively. (C) Representative raw image of the extracellular domain of LPHN3. Scale bar is 100 nm. (D) Nine
representative class averages of the individual particles. Scale bar is 20 nm. (E) Histogram of the distribution of inter-domain distances of individual
particles. No particles were found to be separated by less than 33 Å or more than 153 Å. (F) Schematic model of the extracellular domain of LPHN3.
Because of the slight difference is size of each domain, we tentatively assigned the larger domain to the Lectin and Olfactomedin domains, and the
smaller domain to the HRD, GAIN, and GPS domains. In the proximal globular domain we manually superimposed a ribbon model of the available
crystal structure [17]. (G) O-linked sugar analysis of the N-terminal domain of LPHN3 truncated at residue 571, just before the HRD. Several O-linked
sugars and one N-linked glycosylation were present, as predicted by bioinformatics tools. Known glycans are indicated above the corresponding
spectra. Sugars are represented as follows: yellow circle, galactose; blue square, N-acetylglucosamine; orange square, N-acetylgalactosamine; pink
diamond, N-acetylneuraminic acid; red triangle, fucose; cyan diamond, N-glycolylneuraminic acid. (H) Domain organization of LPHN3. The extracellular
domain of LPHN3 is composed of two globular regions separated by a flexible linker. The distal globular domain contains Lectin and Olfactomedin
homology domains, while the proximal globular domain contains the HRD and GAIN domains.
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source of the rigidity of the stalk domain, we analyzed
the presence of O-linked oligosaccharide by MALDI-TOF/
TOF mass spectrometry of per-O-methylated O-glycan and
we determined that the protein has numerous O-linked
sugars (Figure 4G). Using a deletion mutant that lacks the
potential O-linked glycosylation domain, we conducted a
similar mass spectrometry glycan analysis we found that
the single N-linked glycosylation site predicted on the
Asn532 and several O-glycan species were undetectable or
observed in trace amount (data not shown). Thus, we
found strong evidence that the region comprised by amino
acids 495 to 565 is rigidified by a large number of O-linked
sugars and one N-linked oligosaccharide, as predicted by
bioinformatics tools.FLRTs and TENs bind to different but overlapping parts
of LPHN3
LPHN3 has two classes of identified ligands, the FLRTs
and TENs [8]. In order to map the ligand-binding do-
mains of LPHN3, we created a series of deletion mu-
tants lacking the identifiable conserved protein-protein
interaction domains of the LPHN3 extracellular domain:
Lectin, Olfactomedin, and Hormone Receptor (HRD) do-
mains (Figure 5A). First we verified surface expression of
all mutant LPHN3s by surface staining for an extracellular
HA epitope tag (Figure 5B), and confirmed that control Fc
protein did not bind to LPHN3 expressing cells (data not
shown). Then we expressed LPHN3 constructs in HEK
cells and assessed binding of soluble FLRT3 ectodomain










Figure 5 The Olfactomedin domain of LPHN3 is required for FLRT3 binding while the Olfactomedin and Lectin domains both
contribute to TEN1 binding. (A) Schematics of epitope-tagged wild-type (WT) LPHN3 and protein-protein interaction domain mutants. The GPCR
domain spans the plasma membrane (dotted line), the N-terminus of the extracellular domain has an HA tag, and the C-terminus of the intracellular
domain has a FLAG tag. (B) Immunostaining for surface (HA live-labeling) and total (FLAG permeablized) WT and mutant LPHN3 proteins in transfected
HEK cells. (C) Binding of ecto-FLRT3-Fc to HEK cells expressing GFP, WT LPHN3, or mutant LPHN3. (D) Binding of Fc-ecto-TEN1 conditioned media to
HEK cells expressing GFP, WT LPHN3, or mutant LPHN3. Binding was categorized as strong (+++), weak (+), or absent (-). Scale bars = 10 μm.
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tions, but deletion of the LPHN3 Olfactomedin do-
main (ΔOlfactomedin) nearly abolished FLRT3 binding
(Figure 5C). Next we tested binding to the ectodomain
of Teneurin-1 (Fc-TEN1), and found that both the ΔLectin
and ΔOlfactomedin mutations compromised the ability of
LPHN3 to bind Fc-TEN1 (Figure 5D). Finally, since an
interaction between NRXNs and LPHN1 has recently
be reported [18], we tested binding of NRXN1β(-S4)-
Fc to LPHN3. Binding of NRXN1β(-S4)-Fc to LPHN3
was not reliably detected above background, whereas
NRXN1β(-S4)-Fc bound strongly to LRRTM2-expressing
HEK cells (data not shown). Thus we confirmed that
FLRTs and TENs both bind to LPHN3, but that their
binding involves different but partially overlapping por-
tions of the LPHN3 extracellular domain that are constitu-
ents of the distal globular domain.
The Olfactomedin domain is required for the
synapse-promoting function of LPHN3
After mapping the domains of LPHN3 involved in bind-
ing to FLRT3 and TEN1, we decided to test whether the
ligand-binding domains of LPHN3 are required for itseffect on synapse development. To assess the function of
LPHN3 mutants, we co-electroporated wild-type or mu-
tant LPHN3 plasmids along with shLPHN3 and analyzed
synaptic puncta in L5 (Figure 6A). We found that the dif-
ferent deletions had different effects on synaptic puncta
density; deletion of the Olfactomedin domain prevented
rescue of the synaptic phenotype, while the HRD and Lec-
tin mutants remained capable of rescue (Figure 6B). To-
gether with our binding data (Figure 5B,C), these data
suggest that the same region of LPHN3 - the Olfactomedin
domain - is required for both binding to FLRT3 and sup-
porting normal synaptic output density, while deletion of
the Lectin domain, which impairs binding to TEN1, does
not affect synapse density.
Discussion
We previously identified FLRT3 as an endogenous LPHN
ligand, and identified a role for FLRT3 in the development
of glutamatergic synapses [8]. In this study, we found sup-
port for the hypothesis that presynaptic LPHN3 regulates
the strength of L2/3 input to L5 (Figure 1) by controlling
the number of synapses formed by L2/3 axons (Figure 3).
Using single particle electron microscopy, we determined
Olf LecHRD
Figure 6 The Olfactomedin domain of LPHN3 is required for
development of normal synaptic output density. (A) Example
images of L2/3 axons in L5 from P14 mice electroporated with
Syp-GFP shLPHN3 plasmids and wild-type (WT) or mutant LPHN3
plasmids. Scale bar = 5 μm. (B) Deleting domains of LPHN3
differentially affects the capability of the protein to rescue axonal
synapse density (One-way ANOVA, F(4,299) = 10.07, P <0.0001: WT
Rescue, 1.00 ± 0.06, n = 63; shLPHN3, 0.72 ± 0.06, n = 55; ΔLec 0.95 ±
0.05, n = 66; ΔOlf 0.76 ± 0.04, n = 63; ΔHRD 1.13 ± 0.05, n = 57).
Post-hoc Dunnett tests show that the shLPHN3 and ΔOlf conditions
differ from the WT Rescue (P <0.01). (C) Schematic of the domain
organization of LPHN3 and summary of structure-function results.
Conserved protein-protein interaction domains are labeled in the
schematic, with the functions they subserve indicated by the bars
above them. The extracellular domain of LPHN3 is composed of two
globular regions separated by a flexible linker. The distal globular
domain serves as a ligand-binding module, and FLRTs and TENs
interact with different portions therein.
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two globular domains separated by an elongated O-
glycosylated linker region (Figure 4). We mapped the
ligand-binding domains of LPHN3, and found that the
Olfactomedin domain is required for FLRT3 binding,
whereas the Lectin and Olfactomedin domains are both
involved in binding to TEN1 (Figure 5). The distal
globular domain of LPHN3 contains both the Lectin
and Olfactomedin domains, suggesting it may serve as a
‘ligand-binding module’ on a stalk long enough to
bridge the synaptic cleft. Mutant LPHN3 lacking the
Olfactomedin domain was not able to support the syn-
apse promoting function of LPHN3, while the Lectin
and HRD domains were dispensable (Figure 6). That the
Olfactomedin domain was required while the Lectin do-
main was not necessary suggests that LPHN3 may need
the capability of interacting with FLRTs but not Teneurins
for this function. These results are consistent with our hy-
pothesis that a trans-synaptic interaction between LPHN3
with FLRT3 positively regulates synapse development.
While our experiments suggest that FLRTs and not
Teneurins interact with LPHN3 to support synapse devel-
opment, Teneurins also have described roles in synapse
and circuit development in Drosophila [19,20] and mouse
[21]. In these studies, Teneurins have been postulated to
act through trans-synaptic homophilic binding, but the
interaction of LPHNs with Teneurins may support a pres-
ently unknown LPHN function. Compared to FLRTs,
Teneurins may act at other types of synapses, at a different
time in development, or to fulfill a separate function.
Alternatively, it may be that FLRTs and TENs are
expressed by different subpopulations of neurons within
L5. L5 can be divided into sub-layers (L5a and L5b) with
different patterns of connectivity and molecular deter-
minants of synapse development [16,22]. Our experi-
ments may most accurately represent L5b. Interestingly,
Tenm1 may be more highly expressed in superficial L5
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and TEN expression with markers for sublayer or pro-
jection target are needed to elucidate expression of
these genes by more specific subpopulations of neurons.
More thorough characterization of Latrophilin, FLRT,
and Teneurin expression by cell type and subcellular
localization would be valuable to understand the full range
of locations within the nervous system that Latrophilin in-
teractions may occur. Our experiments did not support
the hypothesis that LPHN3 regulates presynaptic vesicle
release (Figure 2); it may be that the role of LPHN3 in
controlling the rate of synaptic connectivity that we de-
scribe here is its primary role, but it could have different
functions in different contexts.
Since LPHNs may interact with several ligands, it is
possible that the functions of LPHNs are diverse and
ligand-dependent. NRXNs set a precedent for such a
hypothesis; NRXNs can participate in trans-synaptic in-
teractions with neuroligins, LRRTMs, and CBLN-GluRδ
complexes [23]. Further describing the distribution of
these presynaptic proteins, the selectivity and exclusivity
of their trans-synaptic interactions, and functional conse-
quences of binding to different ligands remains imperative
in order to understand the molecular logic underlying syn-
apse development. The diversity of synaptic organizing
proteins might allow the synapses formed between differ-
ent classes of neurons to exhibit unique functional proper-
ties, such as the striking presynaptic facilitation conferred
by postsynaptic ELFN1 at synapses formed onto certain
classes of interneurons [24].
Our structural data also reveal some parallels to prece-
dents set by NRXNs and Neuroligins. We found that the
extracellular domain of LPHN3 has a characteristic archi-
tecture, with the Lectin and Olfactomedin domains and the
HRD and GAIN domains forming two globular domains
separated by a linker region that is rigidified by O-linked
sugars, thus constituting a stalk reminiscent of other synap-
tic proteins such as the neuroligins and the neurexins [25].
This feature suggests that the ligand-binding module of
LPHN3 may extend across the synaptic cleft, placing it in a
position to interact with postsynaptic FLRTs.
In light of the association between LPHN3 and ADHD
[2-4] and our evidence indicating that LPHN3 plays a role
in the development of glutamatergic synapses in the cortex,
it is possible that developmental synaptic abnormalities
might underlie ADHD. Prevailing models of ADHD have
focused on catecholamine modulation of prefrontal cortex
due to the therapeutic efficacy of drugs targeting dopamin-
ergic and noradrenergic pathways [26]. We speculate that
an underlying defect in the development of glutamatergic
synapses in the cortex - as might be caused by mutations in
LPHN3 - could be involved in the circuit dysfunction that
manifests as ADHD in addition to dysregulation of the neu-
romodulatory environment.Conclusions
Latrophilins are a small family of adhesion GPCRs whose
role in the nervous system has only recently come under
scrunity. An important role at synapses for LPHNs has
been implied by two observations, however: (1) LPHN1 is a
receptor for the black widow spider venom protein α-
latrotoxin, which potently stimulates exocytosis; and (2)
variants in the LPHN3 gene have been linked to ADHD in
humans. We investigated the function of presynaptic
LPHN3 in mouse cortex using complementary optogenetic
and anatomical techniques, and found that loss of pre-
synaptic LPHN3 from L2/3 pyramidal neurons reduced the
strength of L2/3 synaptic input to L5 and reduced the dens-
ity of synaptic puncta formed by axons of L2/3 neurons in
L5. We then investigated the structure of the LPHN3 extra-
cellular domain with respect to its ligand binding and syn-
apse promoting functions. Using single particle electron
microscopy, we found that the extracellular domain con-
sists of a pair of globular domains separated by a glycosyl-
ated linker region. The distal globular domain serves as a
ligand-binding module, containing the overlapping but dif-
ferentiable regions that bind to FLRT3 and Teneurin 1.
Mutations in the Olfactomedin domain that prevent
FLRT3 binding also impair synapse density, while muta-
tions in the Lectin domain that impair Teneurin 1 bind-
ing do not affect synapse density. We hypothesize that the
interaction of presynaptic LPHN3 with postsynaptic FLRTs,
but not Teneurins, supports synaptic development.
Methods
Plasmids
pCAG Cre and pCAG H2b-GFP-2A-myrTdTomato were
provided by Corey Harwell and Arnold Kriegstein. pCAG
DIO Syp-GFP was provided by Sebastian Espinosa and
Michael Stryker. pAAV EF1-DIO-hChR2(ET/TC)-eYFP
was provided by Karl Deisseroth. The LPHN3 shRNA was
previously described [8] and targets nucleotides 958-977 of
mouse LPHN3 mRNA (NM198702.2). The LPHN3 rescue
construct was generated by making the following silent mu-
tations in the shRNA target sequence: CCgGAcGCtTA-
cAAaATcA. Deletions were made by PCR, removing the
following nucleotides: ΔLec, 844-1,086; ΔOlf, 1,129-1,896;
ΔHRD, 2,200-2,394. The construct used for EM experiment
(see below) encompassed amino acid residues 21 to 944.
In utero electroporation
All experiments involving mice in this study were car-
ried out in accordance with protocols approved by the
IACUC at the University of California San Diego and
were performed in accordance with institutional and
federal guidelines.
Embryonic day 16 (E16) mouse embryos from timed preg-
nant CD1 mice (Charles River) were injected intraventricu-
larly with DNA and 0.01% Fast Green and electroporated
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Apparatus) and a CUY21 electroporator (BEX) using the
following parameters: 36 V, 5 75 ms pulses at 1 Hz. For
Syp-GFP experiments, the ratio of plasmids was 1:6:3:5
pCAG Cre: pCAG DIO Syp-GFP: pCAG H2b-GFP-2A-
myrTdTomato: pCAG HA-LPHN3-FLAG. For ChR2 experi-
ments, the ratio of plasmids was 1:3:1.3 pCAG Cre: pAAV
EF1α-DIO-hChR2(ET/TC)-eYFP: pCAG HA-LPHN3-FLAG.
Electrophysiology
Acute coronal sections of somatosensory cortex of
300 μm were cut at approximately P14 in an artificial cere-
brospinal fluid (ACSF) consisting of (in mM): 83 NaCl, 2.5
KCl, 1 NaH2PO4, 26.2 NaHCO3, 22 glucose, 72 sucrose,
0.5 CaCl2, 3.3 MgSO4. Slices recovered at 32°C for 1 h,
and were then maintained at room temperature. Whole
cell recordings were made from L5 pyramidal neurons at
room temperature in ACSF consisting of (in mM): 119 NaCl,
2.5 KCl, 1 NaH2PO4, 26 NaHCO3, 2.5 CaCl2, 1.3 MgSO4, 11
glucose, 0.1 picrotoxin, and 0.02 DNQX. EPSCs were evoked
with 1 ms flashes of blue light controlled by a SmartShutter
(Sutter Instruments) and delivered through the 40× object-
ive. Cells were selected for recording from near the center of
the band of ChR2-expressing axons seen in L5. The internal
solution contained (in mM): 130 Cs-methanesulfonate, 5
NaCl, 10 EGTA, 10 HEPES, 10 phosphocreatine, and 2 Mg-
ATP, pH 7.3 with CsOH, 290 mOsm. Data were analyzed in
Clampfit 10 (Molecular Devices) and statistical analyses per-
formed with Prism 6 (GraphPad).Immunohistochemistry and confocal imaging
Mice were transcardially perfused at P14 or P21 with
4% PFA in PBS, the brains post-fixed overnight, and
150 μm coronal sections cut on a vibratome. Slices were
blocked and permeabilized overnight in PBS with 3%
BSA and 0.2 Triton X-100, then immunostained with
1:2,000 Goat anti-GFP (Abcam ab6673) and 1:500 Rabbit
anti-RFP (MBL PM005).
Slices were imaged at 63× on a Leica SP5 confocal
microscope, and stacks acquired with a Z-step size of
0.5 μm. Axon segment length was measured using the
Simple Neurite Tracer plugin [27], the GFP signal thre-
sholded, and the number of GFP puncta along the axon
segment counted manually. All Syp-GFP experiments
were performed in cohorts of two to three litters and one
to three mice per litter, with each step of the experiment
performed in parallel. Imaging thresholds were selected to
achieve a consistent maximum puncta size by surveying
the images in each cohort, and the threshold held for each
cohort. Imaging and analysis was performed blind to con-
dition. Each cohort included a control, and control data
were consistent between cohorts. Statistical analyses were
performed with Prism 6 (GraphPad).Protein binding experiments
FLRT3-Fc protein was produced as previously described
[8]. The extracellular C-terminus of TEN1 was cloned
in frame with human Fc to create an Fc-TEN1 plasmid.
Purified Fc proteins (4 μg/mL) or conditioned media
were added to transfected HEK cells, the cells were in-
cubated at room temperature for 1 h, then washed,
fixed, and immunostained.
LPHN3 expression and purification
To purify soluble LPHN3, the medium containing the se-
creted extracellular domain of LPHN3 was passed over a
protein A column (Captiv-A PriMab affinity resin by
RepliGen), washed and eluted by 3CPro cleavage in TNED
(50 mM Tris pH 8.0, 150 mM NaCl, 1 mM EDTA, 1 mM
DTT) and 5 μM Leupeptin. The eluted LPHN3 protein
was fractionated by size exclusion chromatography using a
Superdex 200 10/300GL (GE Healthcare) column at 4°C
and fraction C3 was used for EM experiments.
Glycan analysis
Glycan analysis was performed by the UCSD Glycotech-
nology Core Resource. O-glycan from protein sample was
liberated by reductive-beta elimination followed by per-O-
methylation. The methylated O-glycans were dissolved in
MeOH and mixed in 1:1 ratio with super-DHB matrix and
spotted on MALDI plate. The mass spectra were acquired
in positive mode and the plausible structure of the ions
was extracted from the database using GlycoWorkbench
software. The structures were proposed after comparing
the mono-saccharide composition analysis, although vari-
ation in the orientation and linkages are possible.
Specimen preparation and single particle electron
microscopy
The purified extracellular domain of LPHN3, at a concen-
tration of approximately 500 ng/mL, was prepared for EM
using the conventional negative staining procedure [28].
Images were taken at room temperature at a magnification
of 60,000× using a Philips CM12 electron microscope
equipped with a digital camera. The SPIDER suite program
was used for image processing [29]. Particles were win-
dowed into 120 × 120 pixel images. Approximately 1,700
particles were subjected to several rounds of alignment,
multivariate statistical analysis, classification, and image
averaging. Images were finally divided in 50 classes, of
which nine representative classes are shown (Figure 4D).
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